PepGen (PEPG) Other Working Capital Changes (2023 - 2026)
PepGen (PEPG) posted Other Working Capital Changes of -$781000.0 for Q1 2026, little changed sequentially from -$781000.0 in Q4 2025, and down 3.03% YoY from -$805439.5 in Q1 2025.
Analysis
PepGen (PEPG) Other Working Capital Changes (2023 - 2026) Analysis & Trends
PepGen has reported Other Working Capital Changes for 4 years, with the latest figure at -$781000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 3.03% year-over-year to -$781000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 million (up 23.94% YoY) and the FY2025 annual result came in at -$3.1 million, down 3.0% from the prior year.
- Other Working Capital Changes held at -$781000.0 in Q1 2026 per PEPG's latest filing, from -$781000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $686000.0 in Q2 2023 and troughed at -$2.0 million in Q1 2023.
- A 4-year average of -$618846.2 and a median of -$758000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 117.22% in 2024, down 365.89% in 2024.
- Over 4 years, Other Working Capital Changes stood at $323000.0 in 2023, then plunged by 334.67% to -$758000.0 in 2024, then slipped by 3.03% to -$781000.0 in 2025, then changed by 0.0% to -$781000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$781000.0, -$781000.0, and -$781000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -797,000.00 |
| Jun 30, 2026 | -797,000.00 |
| Mar 31, 2026 | -781,000.00 |
| Mar 31, 2026 | -781,000.00 |
| Dec 31, 2025 | -781,000.00 |
| Dec 31, 2025 | -781,000.00 |
| Sep 30, 2025 | -781,000.00 |
| Sep 30, 2025 | -781,000.00 |
| Jun 30, 2025 | -774,000.00 |
| Jun 30, 2025 | -774,000.00 |
| Mar 31, 2025 | -758,000.00 |
| Mar 31, 2025 | -758,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Dec 31, 2024 | -758,000.00 |
| Sep 30, 2024 | -758,000.00 |
| Sep 30, 2024 | -758,000.00 |
| Jun 30, 2024 | -1.82 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Mar 31, 2024 | 336,000.00 |
| Mar 31, 2024 | 336,000.00 |